{"role": "assistant", "content": null, "function_call": {"name": "get_risks", "arguments": "{\"risks\":[{\"Description\":\"Lack of effective pharmaceutical interventions for new strains of pandemics\",\"Impact\":\"Delayed response and ineffective protection against new strains of pandemics\",\"Mitigation\":\"Investing in research and development of rapid response vaccines and antiviral drugs\",\"Technologies\":\"Medical research and development for rapid response vaccines and antiviral drugs\",\"People\":\"Public health organizations, pharmaceutical companies, governments\",\"Owner\":\"Public health organizations, pharmaceutical companies, governments\"},{\"Description\":\"Exclusion of architecture and urbanism from pandemic mitigation strategies\",\"Impact\":\"Lack of effective environmental measures to prevent and mitigate pandemics\",\"Mitigation\":\"Integration of architecture and urban planning into interdisciplinary scientific approaches to pandemics\",\"Technologies\":\"Architectural and urban planning technologies for designing disease-resistant built environments\",\"People\":\"Architects, urban planners, public health experts\",\"Owner\":\"Architects, urban planners, public health organizations\"},{\"Description\":\"Reliance on non-pharmaceutical interventions at the early stage of a pandemic\",\"Impact\":\"Limited effectiveness in controlling the spread of contagious diseases\",\"Mitigation\":\"Development and implementation of more effective non-pharmaceutical interventions combined with pharmaceutical measures\",\"Technologies\":\"Innovative non-pharmaceutical interventions and public health protocols\",\"People\":\"Public health authorities, governments, medical researchers\",\"Owner\":\"Public health authorities, governments, medical research organizations\"}]}"}}